The Global Insulinoma Market is expected to grow at a CAGR of 3% during the forecast period 2022-2028. Insulinoma is a rare form of pancreatic beta-cell tumor that causes excessive secretion of insulin, leading to hypoglycemia. Most insulinomas are benign, but some metastasize. Symptoms of insulinoma can also be life-threatening, with low blood sugar and related symptoms […]
